EML4-ALK V3 drives cell migration through NEK9 and NEK7 kinases in non-small-cell lung cancer | bioRxiv
Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition | EMBO Molecular Medicine
NCI-H2228 Cell Line - EP-CL-0570 | Civic Bioscience
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma. - Abstract - Europe PMC
Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors. - Abstract - Europe PMC
A549/DDP Cell Line - EP-CL-0519 | Civic Bioscience
EMT changes and resistance to ALK-TKIs in H2228 cells exposed to... | Download Scientific Diagram
Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1 | Cell Death & Disease
YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation | Nature Communications
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer - ScienceDirect
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer - ScienceDirect
Sensitivities to ALK inhibitors (crizotinib and alectinib) in... | Download Scientific Diagram
Cells | Free Full-Text | Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement | HTML
Epithelial-mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4-ALK translocation - ScienceDirect
HGF-gene transfection resulted in reducing susceptibility of EML4-ALK... | Download Scientific Diagram
Establishment of ALK-TKI-resistant H2228 cells. (A) H2228-CRR,... | Download Scientific Diagram
Cell Lines Nci H2228 (ATCC) | Bioz | Ratings For Life-Science Research
![PDF] Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b265c0fd1b06a512472598fe7575a0e724931a3/2-Figure1-1.png "PDF] Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells | Semantic Scholar")
PDF] Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells | Semantic Scholar
HER2 regulates cancer stem-like cell phenotype in ALK translocated NSCLC
HUMAN IMPRINTING ENCYCLOPEDIA
Supplemental Materials for BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer - Lung Cancer
Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation - Kim - 2013 - Molecular Oncology - Wiley Online Library
Phase‐separated foci of EML4‐ALK facilitate signalling and depend upon an active kinase conformation | EMBO reports
Cells | Free Full-Text | Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement | HTML
